TY  - GEN
AU  - Keitel,W A
AU  - Kester,K E
AU  - Atmar,R L
AU  - White,A C
AU  - Bond,N H
AU  - Holland,C A
AU  - Krzych,U
AU  - Palmer,D R
AU  - Egan,A
AU  - Diggs,C
AU  - Ballou,W R
AU  - Hall,B F
AU  - Kaslow,D
TI  - Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid
SN  - 0264-410X
PY  - 2000///0113
KW  - Adolescent
KW  - Adult
KW  - Animals
KW  - Antibodies, Protozoan
KW  - blood
KW  - Epitopes, T-Lymphocyte
KW  - Humans
KW  - Lymphocyte Activation
KW  - Malaria Vaccines
KW  - adverse effects
KW  - Merozoite Surface Protein 1
KW  - immunology
KW  - Middle Aged
KW  - Peptide Fragments
KW  - Plasmodium falciparum
KW  - Skin Tests
KW  - T-Lymphocytes, Helper-Inducer
KW  - Tetanus Toxoid
KW  - Vaccines, Synthetic
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1016/s0264-410x(99)00221-2
ER  -